Cardiovascular Stents Market Size Analysis Report - Market Share, Forecast Trends and Outlook (2025-2034)
Description
The global cardiovascular stents market was valued at USD 14.06 Billion in 2024 driven by the rising prevalence of cardiovascular disease and advancements in stent technology across the globe. It is expected to grow at a CAGR of 4.80% during the forecast period 2025-2034 and attain a market value of USD 22.47 Billion by 2034.
Cardiovascular Stents Market Overview
Cardiovascular stents play a crucial role in the treatment of coronary artery disease by angioplasty, maintaining vessel patency, ensuring appropriate blood flow, and preventing restenosis. Current stents are equipped with advanced functions such as drug-releasing abilities and bioresorbable substances, which decrease long-term issues. Stents are used to address artery blockages resulting from atherosclerosis, a condition that can result in heart problems. Stents maintain the openness of arteries, promoting consistent blood circulation and reducing possible issues. The minimally invasive angioplasty procedure entails placing a catheter with a balloon and stent into the narrowed artery to expand the stent and compress the plaque.
Stents have revolutionized interventional cardiology by providing a less invasive choice with faster recovery times and improved patient results and thus contribute significantly to the growth of the cardiovascular stents market. Moreover, the introduction of drug-eluting stents, which are designed to release medication that helps prevent the narrowing of arteries, is likely to elevate the market value in the forecast period. Additionally, the rising improvements in stent technology, increasing healthcare expenditure in emerging economies, and the growing public awareness campaigns on heart disease are some of the factors poised to influence the market dynamics.
Cardiovascular Stents Market Growth Drivers
Rising Prevalence of Cardiovascular Diseases Spurs Market Growth
The rise in cardiovascular diseases (CVDs), due to lifestyle changes, urbanization, and aging populations impacts the global market for cardiovascular stents. In 2023, approximately 620 million people, out of the global population of 8 billion, were living with heart and circulatory diseases. Every year, around 60 million people worldwide develop these conditions, resulting in 1 in 13 individuals having a heart or circulatory disease. Thus, the rising burden of cardiovascular diseases such as coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions, play a significant role in the growth of the market.
Advancements in Stent Technology Drive Increased Demand in the Cardiovascular Stents Market
Improvements in stent technology are driving expansion in the market. Advances in design, materials, and drug delivery systems have enhanced the safety and efficacy of stent procedures. For instance, in March 2024, Boston Scientific obtained FDA approval for the AGENT™ Drug-Coated Balloon, the first of its kind in the U.S. It offers a safe and effective alternative to address coronary in-stent restenosis and lower the risk of recurrence. Further, stents have become more resilient and compatible with the body. This is due to the use of high-strength alloys such as cobalt-chromium and biocompatible polymers.
Cardiovascular Stents Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Growing Geriatric Population to Impact Cardiovascular Stents Market
Conditions like high blood pressure, diabetes, and high cholesterol are common in elderly individuals, which results in a greater need for advanced treatment choices such as cardiovascular stents. Older adults opt for procedures such as stent implantation due to their lower risks and quicker recovery times. As the elderly population continues to grow, the demand for cardiovascular stents is set to increase.
Rising Preference for Minimally Invasive Surgeries Likely to Elevate the Cardiovascular Stents Market Value
Procedures like stent implantation provide benefits such as decreased incision size, less trauma, and quicker recovery periods in comparison to conventional open surgeries. Stent implantation for heart-related issues is commonly performed using a catheter inserted either through the groin or wrist, which reduces risks and accelerates patient healing. Both patients and healthcare providers favor minimally invasive surgeries due to their reduced hospitalization time and faster resumption of everyday tasks.
Increased Awareness and Screening Programs to Augment Cardiovascular Stents Market Demand
Growing awareness of heart health risks is causing people to proactively seek early detection and preventative treatment, driving up the need for cardiovascular stents. Public health initiatives and educational programs are improving understanding of potential risks, and encouraging frequent check-ups. Screening programs assist in identifying individuals at risk, which results in timely stent utilization for blockage management and improved patient results.
Improvement in Healthcare Infrastructure
The increased use of stent technologies is being driven by modern hospitals with enhanced amenities and diagnostic equipment. Improved healthcare facilities are enhancing the ability to perform intricate procedures such as stent implantation with more accuracy and improved results for patients. Enhanced healthcare facilities are also aiding in the accessibility of top-notch stents and improved training for medical professionals, leading to a more efficient utilization of stent technologies.
Cardiovascular Stents Market Segmentation
“Cardiovascular Stents Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Market Segmentation Based on the Type Holds a Significant Market Share
Different types of cardiovascular stents include drug-eluting stents (DES), bioresorbable stents, bare metal stents, dual therapy stents, and various other categories. Drug-eluting stents (DES) are the most frequently utilized because of their notable benefits in preventing restenosis in arteries. These stents release a drug that hinders cell growth and stops the formation of scar tissue, lowering the chance of the artery reoccluding. This technology has shown great success in the results over time, establishing drug-eluting stents as the top option in numerous situations. They are especially advantageous for patients at high risk of restenosis or those with intricate coronary lesions.
The Material Segment is Likely to Fuel Cardiovascular Stents Market Growth
Cardiovascular stents are classified based on the materials used, such as stainless steel, cobalt chromium, nitinol, and polymers. Cobalt chromium stents are preferred due to their strength and flexibility, allowing for thinner designs and improved deliverability. They provide excellent radial strength, decreasing the chance of deformation and supporting the overall health of arteries in the long run. Additionally, these stents are resistant to corrosion and have a smaller design for simpler maneuverability.
Cardiovascular Stents Market Analysis by Region
Based on region, the market report covers North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.
North America is expected to dominate the market powered by its state-of-the-art healthcare facilities, high rates of cardiovascular disease, and emphasis on medical progress. In the United States, heart disease is the top cause of death for most groups, with one person dying every 33 seconds with 702,880 deaths in 2022. Market growth is fostered by the presence of modern stent technologies such as drug-eluting and bioresorbable stents. Continual research and development, governmental support, and the rising preference for less intrusive techniques play a crucial role in the region's dominance in the cardiovascular stents market.
Europe is also poised to have a significant market share supported by the high prevalence of cardiovascular diseases, cutting-edge medical technologies, and favorable healthcare policies. Cardiovascular diseases are the main cause of disability and premature death in Europe, accounting for 42.5% of annual deaths, which is 10,000 per day. Nations such as Germany, France, and the United Kingdom experience a substantial burden of cardiovascular diseases, leading to an increased need for stent placement. The area adopts modern stent technologies such as drug-eluting and bioresorbable stents, backed by regulatory approvals and health authorities, which further aids the market expansion in the region.
Leading Players in the Cardiovascular Stents Market
The key features of the market report include patent analysis, funding, and investment analysis as well as strategic initiatives including recent partnerships and collaborations by the leading players. The major companies in the market are as follows:
Cordis US Corp
Cordis is an American medical company developing and manufacturing devices for coronary and vascular diseases. In Oct 2022, Cordis announced the acquisition of MedAlliance, a Swiss company specializing in drug-eluting balloons. By acquiring MedAlliance, Cordis aims to serve two million patients worldwide by 2027 with their innovative SELUTION SLR drug-eluting balloon.
Abbott Laboratories
Abbott Laboratories is a US-based healthcare company that develops and sells medical products including pharmaceuticals, diagnostics, and nutritional items. In February 2023, Abbott acquired Cardiovascular Systems, Inc., a leader in atherectomy devices for treating artery disease. The deal is valued at USD 890 million, with CSI shareholders receiving USD 20 per share.
Boston Scientific Corporation
Boston Scientific Corporation, headquartered in Marlborough, Massachusetts, is a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices. The company is known for its advanced stent products, which are widely used in the treatment of coronary artery disease.
Medtronic Plc
Medtronic plc, an American-Irish medical device company, received FDA approval in May 2022 for the latest generation drug-eluting coronary stent system - the Onyx Frontier DES. This stent, part of the Resolute DES family, improves deliverability and acute performance in challenging cases, utilizing a best-in-class stent platform.
Other players in the market are BIOTRONIK SE & Co KG, MicroPort Scientific Corporation, Cardinal Health Inc., Cook Medical Inc., C. R. Bard, Inc. (BD), Terumo Corporation, and B. Braun Melsungen AG.
Key Questions Answered in the Cardiovascular Stents Market Report
Cardiovascular Stents Market Overview
Cardiovascular stents play a crucial role in the treatment of coronary artery disease by angioplasty, maintaining vessel patency, ensuring appropriate blood flow, and preventing restenosis. Current stents are equipped with advanced functions such as drug-releasing abilities and bioresorbable substances, which decrease long-term issues. Stents are used to address artery blockages resulting from atherosclerosis, a condition that can result in heart problems. Stents maintain the openness of arteries, promoting consistent blood circulation and reducing possible issues. The minimally invasive angioplasty procedure entails placing a catheter with a balloon and stent into the narrowed artery to expand the stent and compress the plaque.
Stents have revolutionized interventional cardiology by providing a less invasive choice with faster recovery times and improved patient results and thus contribute significantly to the growth of the cardiovascular stents market. Moreover, the introduction of drug-eluting stents, which are designed to release medication that helps prevent the narrowing of arteries, is likely to elevate the market value in the forecast period. Additionally, the rising improvements in stent technology, increasing healthcare expenditure in emerging economies, and the growing public awareness campaigns on heart disease are some of the factors poised to influence the market dynamics.
Cardiovascular Stents Market Growth Drivers
Rising Prevalence of Cardiovascular Diseases Spurs Market Growth
The rise in cardiovascular diseases (CVDs), due to lifestyle changes, urbanization, and aging populations impacts the global market for cardiovascular stents. In 2023, approximately 620 million people, out of the global population of 8 billion, were living with heart and circulatory diseases. Every year, around 60 million people worldwide develop these conditions, resulting in 1 in 13 individuals having a heart or circulatory disease. Thus, the rising burden of cardiovascular diseases such as coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions, play a significant role in the growth of the market.
Advancements in Stent Technology Drive Increased Demand in the Cardiovascular Stents Market
Improvements in stent technology are driving expansion in the market. Advances in design, materials, and drug delivery systems have enhanced the safety and efficacy of stent procedures. For instance, in March 2024, Boston Scientific obtained FDA approval for the AGENT™ Drug-Coated Balloon, the first of its kind in the U.S. It offers a safe and effective alternative to address coronary in-stent restenosis and lower the risk of recurrence. Further, stents have become more resilient and compatible with the body. This is due to the use of high-strength alloys such as cobalt-chromium and biocompatible polymers.
Cardiovascular Stents Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Growing Geriatric Population to Impact Cardiovascular Stents Market
Conditions like high blood pressure, diabetes, and high cholesterol are common in elderly individuals, which results in a greater need for advanced treatment choices such as cardiovascular stents. Older adults opt for procedures such as stent implantation due to their lower risks and quicker recovery times. As the elderly population continues to grow, the demand for cardiovascular stents is set to increase.
Rising Preference for Minimally Invasive Surgeries Likely to Elevate the Cardiovascular Stents Market Value
Procedures like stent implantation provide benefits such as decreased incision size, less trauma, and quicker recovery periods in comparison to conventional open surgeries. Stent implantation for heart-related issues is commonly performed using a catheter inserted either through the groin or wrist, which reduces risks and accelerates patient healing. Both patients and healthcare providers favor minimally invasive surgeries due to their reduced hospitalization time and faster resumption of everyday tasks.
Increased Awareness and Screening Programs to Augment Cardiovascular Stents Market Demand
Growing awareness of heart health risks is causing people to proactively seek early detection and preventative treatment, driving up the need for cardiovascular stents. Public health initiatives and educational programs are improving understanding of potential risks, and encouraging frequent check-ups. Screening programs assist in identifying individuals at risk, which results in timely stent utilization for blockage management and improved patient results.
Improvement in Healthcare Infrastructure
The increased use of stent technologies is being driven by modern hospitals with enhanced amenities and diagnostic equipment. Improved healthcare facilities are enhancing the ability to perform intricate procedures such as stent implantation with more accuracy and improved results for patients. Enhanced healthcare facilities are also aiding in the accessibility of top-notch stents and improved training for medical professionals, leading to a more efficient utilization of stent technologies.
Cardiovascular Stents Market Segmentation
“Cardiovascular Stents Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
- Coronary Stenting
- Peripheral Stenting
- Drug Eluting Stents (DES)
- Bioresorbable Stents
- Bare Metal Stents
- Dual Therapy Stent
- Others
- Stainless Steel
- Cobalt Chromium
- Nitinol
- Polymers
- Venous Diseases
- Arterial Diseases
- Hospitals
- Ambulatory Surgery Centres
- Speciality Clinics
- Catheterisation Labs
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Market Segmentation Based on the Type Holds a Significant Market Share
Different types of cardiovascular stents include drug-eluting stents (DES), bioresorbable stents, bare metal stents, dual therapy stents, and various other categories. Drug-eluting stents (DES) are the most frequently utilized because of their notable benefits in preventing restenosis in arteries. These stents release a drug that hinders cell growth and stops the formation of scar tissue, lowering the chance of the artery reoccluding. This technology has shown great success in the results over time, establishing drug-eluting stents as the top option in numerous situations. They are especially advantageous for patients at high risk of restenosis or those with intricate coronary lesions.
The Material Segment is Likely to Fuel Cardiovascular Stents Market Growth
Cardiovascular stents are classified based on the materials used, such as stainless steel, cobalt chromium, nitinol, and polymers. Cobalt chromium stents are preferred due to their strength and flexibility, allowing for thinner designs and improved deliverability. They provide excellent radial strength, decreasing the chance of deformation and supporting the overall health of arteries in the long run. Additionally, these stents are resistant to corrosion and have a smaller design for simpler maneuverability.
Cardiovascular Stents Market Analysis by Region
Based on region, the market report covers North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.
North America is expected to dominate the market powered by its state-of-the-art healthcare facilities, high rates of cardiovascular disease, and emphasis on medical progress. In the United States, heart disease is the top cause of death for most groups, with one person dying every 33 seconds with 702,880 deaths in 2022. Market growth is fostered by the presence of modern stent technologies such as drug-eluting and bioresorbable stents. Continual research and development, governmental support, and the rising preference for less intrusive techniques play a crucial role in the region's dominance in the cardiovascular stents market.
Europe is also poised to have a significant market share supported by the high prevalence of cardiovascular diseases, cutting-edge medical technologies, and favorable healthcare policies. Cardiovascular diseases are the main cause of disability and premature death in Europe, accounting for 42.5% of annual deaths, which is 10,000 per day. Nations such as Germany, France, and the United Kingdom experience a substantial burden of cardiovascular diseases, leading to an increased need for stent placement. The area adopts modern stent technologies such as drug-eluting and bioresorbable stents, backed by regulatory approvals and health authorities, which further aids the market expansion in the region.
Leading Players in the Cardiovascular Stents Market
The key features of the market report include patent analysis, funding, and investment analysis as well as strategic initiatives including recent partnerships and collaborations by the leading players. The major companies in the market are as follows:
Cordis US Corp
Cordis is an American medical company developing and manufacturing devices for coronary and vascular diseases. In Oct 2022, Cordis announced the acquisition of MedAlliance, a Swiss company specializing in drug-eluting balloons. By acquiring MedAlliance, Cordis aims to serve two million patients worldwide by 2027 with their innovative SELUTION SLR drug-eluting balloon.
Abbott Laboratories
Abbott Laboratories is a US-based healthcare company that develops and sells medical products including pharmaceuticals, diagnostics, and nutritional items. In February 2023, Abbott acquired Cardiovascular Systems, Inc., a leader in atherectomy devices for treating artery disease. The deal is valued at USD 890 million, with CSI shareholders receiving USD 20 per share.
Boston Scientific Corporation
Boston Scientific Corporation, headquartered in Marlborough, Massachusetts, is a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices. The company is known for its advanced stent products, which are widely used in the treatment of coronary artery disease.
Medtronic Plc
Medtronic plc, an American-Irish medical device company, received FDA approval in May 2022 for the latest generation drug-eluting coronary stent system - the Onyx Frontier DES. This stent, part of the Resolute DES family, improves deliverability and acute performance in challenging cases, utilizing a best-in-class stent platform.
Other players in the market are BIOTRONIK SE & Co KG, MicroPort Scientific Corporation, Cardinal Health Inc., Cook Medical Inc., C. R. Bard, Inc. (BD), Terumo Corporation, and B. Braun Melsungen AG.
Key Questions Answered in the Cardiovascular Stents Market Report
- What was the global cardiovascular stents market value in 2023?
- What is the global cardiovascular stents market forecast outlook for 2025-2034?
- What are the regional markets covered in the EMR report?
- What is the market segmentation based on the product type?
- What is the market breakup by type?
- What is the market segmentation based on material?
- What is the market breakup based on disease indication?
- What is the market breakup based on the end user?
- What are the major factors aiding the global cardiovascular stents market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the major drivers, opportunities, and restraints in the market?
- What are the major trends influencing the market?
- Which regional market is expected to dominate the market share in the forecast period?
- Which country is likely to experience elevated growth during the forecast period?
- Who are the key players involved in the global cardiovascular stents market?
- What is the patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Table of Contents
400 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Cardiovascular Stents Market Overview
- 3.1 Global Cardiovascular Stents Market Historical Value (2018-2024)
- 3.2 Global Cardiovascular Stents Market Forecast Value (2025-2034)
- 4 Vendor Positioning Analysis
- 4.1 Key Vendors
- 4.2 Prospective Leaders
- 4.3 Niche Leaders
- 4.4 Disruptors
- 5 Global Cardiovascular Stents Market Landscape*
- 5.1 Global Cardiovascular Stents Market: Developers Landscape
- 5.1.1 Analysis by Year of Establishment
- 5.1.2 Analysis by Company Size
- 5.1.3 Analysis by Region
- 5.2 Global Cardiovascular Stents Market: Product Landscape
- 5.2.1 Analysis by Product Type
- 5.2.2 Analysis by Stent Type
- 5.2.3 Analysis by Material
- 5.2.4 Analysis by Disease Indication
- 6 Global Cardiovascular Stents Market Dynamics
- 6.1 Market Drivers and Constraints
- 6.2 SWOT Analysis
- 6.2.1 Strengths
- 6.2.2 Weaknesses
- 6.2.3 Opportunities
- 6.2.4 Threats
- 6.3 PESTEL Analysis
- 6.3.1 Political
- 6.3.2 Economic
- 6.3.3 Social
- 6.3.4 Technological
- 6.3.5 Legal
- 6.3.6 Environment
- 6.4 Porter’s Five Forces Model
- 6.4.1 Bargaining Power of Suppliers
- 6.4.2 Bargaining Power of Buyers
- 6.4.3 Threat of New Entrants
- 6.4.4 Threat of Substitutes
- 6.4.5 Degree of Rivalry
- 6.5 Key Demand Indicators
- 6.6 Key Price Indicators
- 6.7 Industry Events, Initiatives, and Trends
- 6.8 Value Chain Analysis
- 7 Global Cardiovascular Stents Market Segmentation (218-2034)
- 7.1 Global Cardiovascular Stents Market (2018-2034) by Product Type
- 7.1.1 Market Overview
- 7.1.2 Coronary Stenting
- 7.1.3 Peripheral Stenting
- 7.2 Global Cardiovascular Stents Market (2018-2034) by Type
- 7.2.1 Market Overview
- 7.2.2 Drug Eluting Stents (DES)
- 7.2.3 Bioresorbable Stents
- 7.2.4 Bare Metal Stents
- 7.2.5 Dual Therapy Stent
- 7.2.6 Others
- 7.3 Global Cardiovascular Stents Market (2018-2034) by Material
- 7.3.1 Market Overview
- 7.3.2 Stainless Steel
- 7.3.3 Cobalt Chromium
- 7.3.4 Nitinol
- 7.3.5 Polymers
- 7.4 Global Cardiovascular Stents Market (2018-2034) by Disease Indication
- 7.4.1 Market Overview
- 7.4.2 Venous Diseases
- 7.4.3 Arterial Diseases
- 7.5 Global Cardiovascular Stents Market (2018-2034) by End User
- 7.5.1 Market Overview
- 7.5.2 Hospitals
- 7.5.3 Ambulatory Surgery Centres
- 7.5.4 Speciality Clinics
- 7.5.5 Catheterisation Labs
- 7.6 Global Cardiovascular Stents Market (2018-2034) by Region
- 7.6.1 Market Overview
- 7.6.2 North America
- 7.6.3 Europe
- 7.6.4 Asia Pacific
- 7.6.5 Latin America
- 7.6.6 Middle East and Africa
- 8 North America Cardiovascular Stents Market (218-2034)
- 8.1 North America Cardiovascular Stents Market (2018-2034) by Product Type
- 8.1.1 Market Overview
- 8.1.2 Coronary Stenting
- 8.1.3 Peripheral Stenting
- 8.2 North America Cardiovascular Stents Market (2018-2034) by Type
- 8.2.1 Market Overview
- 8.2.2 Drug Eluting Stents (DES)
- 8.2.3 Bioresorbable Stents
- 8.2.4 Bare Metal Stents
- 8.2.5 Dual Therapy Stent
- 8.2.6 Others
- 8.3 North America Cardiovascular Stents Market (2018-2034) by Material
- 8.3.1 Market Overview
- 8.3.2 Stainless Steel
- 8.3.3 Cobalt Chromium
- 8.3.4 Nitinol
- 8.3.5 Polymers
- 8.4 North America Cardiovascular Stents Market (2018-2034) by Disease Indication
- 8.4.1 Market Overview
- 8.4.2 Venous Diseases
- 8.4.3 Arterial Diseases
- 8.5 North America Cardiovascular Stents Market (2018-2034) by End User
- 8.5.1 Market Overview
- 8.5.2 Hospitals
- 8.5.3 Ambulatory Surgery Centres
- 8.5.4 Speciality Clinics
- 8.5.5 Catheterisation Labs
- 8.6 North America Cardiovascular Stents Market (2018-2034) by Country
- 8.6.1 United States of America
- 8.6.2 Canada
- 9 Europe Cardiovascular Stents Market (218-2034)
- 9.1 Europe Cardiovascular Stents Market (2018-2034) by Product Type
- 9.1.1 Market Overview
- 9.1.2 Coronary Stenting
- 9.1.3 Peripheral Stenting
- 9.2 Europe Cardiovascular Stents Market (2018-2034) by Type
- 9.2.1 Market Overview
- 9.2.2 Drug Eluting Stents (DES)
- 9.2.3 Bioresorbable Stents
- 9.2.4 Bare Metal Stents
- 9.2.5 Dual Therapy Stent
- 9.2.6 Others
- 9.3 Europe Cardiovascular Stents Market (2018-2034) by Material
- 9.3.1 Market Overview
- 9.3.2 Stainless Steel
- 9.3.3 Cobalt Chromium
- 9.3.4 Nitinol
- 9.3.5 Polymers
- 9.4 Europe Cardiovascular Stents Market (2018-2034) by Disease Indication
- 9.4.1 Market Overview
- 9.4.2 Venous Diseases
- 9.4.3 Arterial Diseases
- 9.5 Europe Cardiovascular Stents Market (2018-2034) by End User
- 9.5.1 Market Overview
- 9.5.2 Hospitals
- 9.5.3 Ambulatory Surgery Centres
- 9.5.4 Speciality Clinics
- 9.5.5 Catheterisation Labs
- 9.6 Europe Cardiovascular Stents Market (2018-2034) by Country
- 9.6.1 United Kingdom
- 9.6.2 Germany
- 9.6.3 France
- 9.6.4 Italy
- 9.6.5 Others
- 10 Asia Pacific Cardiovascular Stents Market (218-2034)
- 10.1 Asia Pacific Cardiovascular Stents Market (2018-2034) by Product Type
- 10.1.1 Market Overview
- 10.1.2 Coronary Stenting
- 10.1.3 Peripheral Stenting
- 10.2 Asia Pacific Cardiovascular Stents Market (2018-2034) by Type
- 10.2.1 Market Overview
- 10.2.2 Drug Eluting Stents (DES)
- 10.2.3 Bioresorbable Stents
- 10.2.4 Bare Metal Stents
- 10.2.5 Dual Therapy Stent
- 10.2.6 Others
- 10.3 Asia Pacific Cardiovascular Stents Market (2018-2034) by Material
- 10.3.1 Market Overview
- 10.3.2 Stainless Steel
- 10.3.3 Cobalt Chromium
- 10.3.4 Nitinol
- 10.3.5 Polymers
- 10.4 Asia Pacific Cardiovascular Stents Market (2018-2034) by Disease Indication
- 10.4.1 Market Overview
- 10.4.2 Venous Diseases
- 10.4.3 Arterial Diseases
- 10.5 Asia Pacific Cardiovascular Stents Market (2018-2034) by End User
- 10.5.1 Market Overview
- 10.5.2 Hospitals
- 10.5.3 Ambulatory Surgery Centres
- 10.5.4 Speciality Clinics
- 10.5.5 Catheterisation Labs
- 10.6 Asia Pacific Cardiovascular Stents Market (2018-2034) by Country
- 10.6.1 China
- 10.6.2 Japan
- 10.6.3 India
- 10.6.4 ASEAN
- 10.6.5 Australia
- 10.6.6 Others
- 11 Latin America Cardiovascular Stents Market (218-2034)
- 11.1 Latin America Cardiovascular Stents Market (2018-2034) by Product Type
- 11.1.1 Market Overview
- 11.1.2 Coronary Stenting
- 11.1.3 Peripheral Stenting
- 11.2 Latin America Cardiovascular Stents Market (2018-2034) by Type
- 11.2.1 Market Overview
- 11.2.2 Drug Eluting Stents (DES)
- 11.2.3 Bioresorbable Stents
- 11.2.4 Bare Metal Stents
- 11.2.5 Dual Therapy Stent
- 11.2.6 Others
- 11.3 Latin America Cardiovascular Stents Market (2018-2034) by Material
- 11.3.1 Market Overview
- 11.3.2 Stainless Steel
- 11.3.3 Cobalt Chromium
- 11.3.4 Nitinol
- 11.3.5 Polymers
- 11.4 Latin America Cardiovascular Stents Market (2018-2034) by Disease Indication
- 11.4.1 Market Overview
- 11.4.2 Venous Diseases
- 11.4.3 Arterial Diseases
- 11.5 Latin America Cardiovascular Stents Market (2018-2034) by End User
- 11.5.1 Market Overview
- 11.5.2 Hospitals
- 11.5.3 Ambulatory Surgery Centres
- 11.5.4 Speciality Clinics
- 11.5.5 Catheterisation Labs
- 11.6 Latin America Cardiovascular Stents Market (2018-2034) by Country
- 11.6.1 Brazil
- 11.6.2 Argentina
- 11.6.3 Mexico
- 11.6.4 Others
- 12 Middle East and Africa Cardiovascular Stents Market (218-2034)
- 12.1 Middle East and Africa Cardiovascular Stents Market (2018-2034) by Product Type
- 12.1.1 Market Overview
- 12.1.2 Coronary Stenting
- 12.1.3 Peripheral Stenting
- 12.2 Middle East and Africa Cardiovascular Stents Market (2018-2034) by Type
- 12.2.1 Market Overview
- 12.2.2 Drug Eluting Stents (DES)
- 12.2.3 Bioresorbable Stents
- 12.2.4 Bare Metal Stents
- 12.2.5 Dual Therapy Stent
- 12.2.6 Others
- 12.3 Middle East and Africa Cardiovascular Stents Market (2018-2034) by Material
- 12.3.1 Market Overview
- 12.3.2 Stainless Steel
- 12.3.3 Cobalt Chromium
- 12.3.4 Nitinol
- 12.3.5 Polymers
- 12.4 Middle East and Africa Cardiovascular Stents Market (2018-2034) by Disease Indication
- 12.4.1 Market Overview
- 12.4.2 Venous Diseases
- 12.4.3 Arterial Diseases
- 12.5 Middle East and Africa Cardiovascular Stents Market (2018-2034) by End User
- 12.5.1 Market Overview
- 12.5.2 Hospitals
- 12.5.3 Ambulatory Surgery Centres
- 12.5.4 Speciality Clinics
- 12.5.5 Catheterisation Labs
- 12.6 Middle East and Africa Cardiovascular Stents Market (2018-2034) by Country
- 12.6.1 Saudi Arabia
- 12.6.2 United Arab Emirates
- 12.6.3 Nigeria
- 12.6.4 South Africa
- 12.6.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication Year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Funding and Investment Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Strategic Initiatives
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Supplier Landscape
- 16.1 Market Share Analysis, By Region (Top 5 Companies)
- 16.1.1 Market Share Analysis: Global
- 16.1.2 Market Share Analysis: North America
- 16.1.3 Market Share Analysis: Europe
- 16.1.4 Market Share Analysis: Asia Pacific
- 16.1.5 Market Share Analysis: Others
- 16.2 Cordis US Corp
- 16.2.1 Financial Analysis
- 16.2.2 Product Portfolio
- 16.2.3 Demographic Reach and Achievements
- 16.2.4 Company News and Developments
- 16.2.5 Certifications
- 16.3 BIOTRONIK SE & Co KG
- 16.3.1 Financial Analysis
- 16.3.2 Product Portfolio
- 16.3.3 Demographic Reach and Achievements
- 16.3.4 Company News and Developments
- 16.3.5 Certifications
- 16.4 MicroPort Scientific Corporation
- 16.4.1 Financial Analysis
- 16.4.2 Product Portfolio
- 16.4.3 Demographic Reach and Achievements
- 16.4.4 Company News and Developments
- 16.4.5 Certifications
- 16.5 Abbott Laboratories
- 16.5.1 Financial Analysis
- 16.5.2 Product Portfolio
- 16.5.3 Demographic Reach and Achievements
- 16.5.4 Company News and Developments
- 16.5.5 Certifications
- 16.6 Boston Scientific Corporation
- 16.6.1 Financial Analysis
- 16.6.2 Product Portfolio
- 16.6.3 Demographic Reach and Achievements
- 16.6.4 Company News and Developments
- 16.6.5 Certifications
- 16.7 Medtronic Plc
- 16.7.1 Financial Analysis
- 16.7.2 Product Portfolio
- 16.7.3 Demographic Reach and Achievements
- 16.7.4 Company News and Developments
- 16.7.5 Certifications
- 16.8 Cardinal Health Inc.
- 16.8.1 Financial Analysis
- 16.8.2 Product Portfolio
- 16.8.3 Demographic Reach and Achievements
- 16.8.4 Company News and Developments
- 16.8.5 Certifications
- 16.9 Cook medical Inc.
- 16.9.1 Financial Analysis
- 16.9.2 Product Portfolio
- 16.9.3 Demographic Reach and Achievements
- 16.9.4 Company News and Developments
- 16.9.5 Certifications
- 16.10 C. R. Bard, Inc. (BD )
- 16.10.1 Financial Analysis
- 16.10.2 Product Portfolio
- 16.10.3 Demographic Reach and Achievements
- 16.10.4 Company News and Developments
- 16.10.5 Certifications
- 16.11 Terumo Corporation
- 16.11.1 Financial Analysis
- 16.11.2 Product Portfolio
- 16.11.3 Demographic Reach and Achievements
- 16.11.4 Company News and Developments
- 16.11.5 Certifications
- 16.12 B. Braun Melsungen AG
- 16.12.1 Financial Analysis
- 16.12.2 Product Portfolio
- 16.12.3 Demographic Reach and Achievements
- 16.12.4 Company News and Developments
- 16.12.5 Certifications
- 17 Global Cardiovascular Stents Market – Distribution Model (Additional Insight)
- 17.1 Overview
- 17.2 Potential Distributors
- 17.3 Key Parameters for Distribution Partner Assessment
- 18 Key Opinion Leaders (KOL) Insights (Additional Insight)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
